Pnc Financial Services Group, Inc. 89bio, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in 89bio, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 22,365 shares of ETNB stock, worth $171,986. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,365
Previous 17,505
27.76%
Holding current value
$171,986
Previous $140,000
17.86%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ETNB
# of Institutions
159Shares Held
108MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$117 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$109 Million1.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$61.5 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$56.7 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$53.9 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $357M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...